More On:
johnson & johnson
NYC man tests positive for COVID two weeks after Johnson & Johnson vaccine
CEO at embattled vaccine plant got massive raise in 2020
Man in hospital with COVID after being fully vaccinated
Blood clots in Johnson & Johnson COVID vaccine recipients under investigation
Federal health agencies will temporarily stop using Johnson & Johnson’s one-dose vaccine after six women developed blood clots, including one who died, according to a new report.
The half-dozen patients, who are between the ages of 18 and 48, developed a rare disorder involving blood clots within about two weeks of vaccination.
One died and a second in Nebraska was hospitalized in critical condition. The feds hope the pause will serve as a strong signal to states to do the same.
Nearly 7 million people in the US have gotten the J&J shot so far.
About 9 million more doses have shipped to states, according to the Centers for Disease Control and Prevention.
Share this article:
Source: Read Full Article
